A novel candidate tumor suppressor gene, PTEN gene, known as another effector of PI3K/PTEN/AKT pathway, is always lost by mutations, deletions or promoter methylation silencing at high frequency in many primary and metastatic human cancers, which are important mechanisms for cell cycle progression, survival, metabolism and migration. This evidence concerns the gene PIK3CA and cancer.